In fact, Li and colleagues showed in lung cancer cells that EZH2 targets NFE2L2 promoter, thus suppressing its expression by regulating trimethylation of histone H3 at lysine 27 (H3K27me3) [80]. Here, NFE2L2 is linked to lung cancer.